Investigational drug · Phase 2
LIB-01
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Erectile Dysfunction.
Phase 2Last checked: Nov 19, 2026Latest source record: Aug 24, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
2
Any phase or sponsor naming "LIB-01"
First trial start
2024
Nov 8, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "LIB-01", any sponsor or status.
Conditions studied
As listed on its trial records.
- Erectile Dysfunction
Approved drugs for the same conditions: Erectile dysfunction
Largest trials
Live from ClinicalTrials.gov: studies naming "LIB-01" as an intervention, largest first.
- Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile DysfunctionPivotal-lookingCompleted
Dicot ABIndustry
NCT06703840 · 156 participants · Start Nov 8, 2024 · Primary completion Jul 19, 2025
Drug: LIB-01; LIB-01 Placebo · For: Erectile Dysfunction
Sites: Herlev, Denmark; Groningen, Netherlands; Mölndal, Sweden · 6 sites in all
Dicot ABIndustry
NCT06324006 · 64 participants · Start Aug 25, 2023 · Primary completion Apr 23, 2024
Drug: LIB-01 · For: Erectile Dysfunction
Sites: Uppsala, Sweden
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Erectile Dysfunction
- TestofenPhase 32 trials
RDC Clinical Pty Ltd · Long Covid19, Erectile Dysfunction
- DTT106Phase 31 trial
EMS · Prostatic Hyperplasia, Benign, Erectile Dysfunction
- HGP1201Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HIP2602Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HPP2602-1Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- HPP2602-2Phase 31 trial
Hanmi Pharmaceutical Company Limited · Erectile Dysfunction
- TPN171HSimmerafilPhase 31 trial
Vigonvita Life Sciences · Erectile Dysfunction
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.